Menassa R, Tardy V, Despert F, Bouvattier-Morel C, Brossier J P, Cartigny M, Morel Y
Laboratoire d'Endocrinologie Moléculaire et Maladies Rares, Centre de Biologie et de Pathologie Est, Bron Cedex, France.
J Clin Endocrinol Metab. 2008 May;93(5):1901-8. doi: 10.1210/jc.2007-2701. Epub 2008 Mar 4.
Steroid 21-hydroxylase deficiency is the most common enzymatic defect causing congenital adrenal hyperplasia with good genotype/phenotype relationships for common mutations. To determine the severity of rare mutations is essential for genetic counseling and better understanding of the structure-function of the cytochrome P450c21.
The p.H62L mutation was the most frequent of 60 new mutations detected in 2900 steroid 21-hydroxylase deficiency patients, either isolated or associated on the same allele with a mild mutation (p.P453S, p.P30L, or partial promoter). Because phenotypes seemed to differ between patients with isolated or associated p.H62L, a detailed phenotype description and functional studies were performed.
Regarding phenotype, patients with isolated p.H62L had a nonclassical form, whereas patients with the association p.H62L + mild mutation had a simple virilizing form. Functional studies showed that p.H62L reduced the conversion of the two substrates, progesterone and 17-hydroxyprogesterone, in the same way as the mild p.P453S; the association p.H62L + p.P453S decreased enzymatic activity more strongly while conserving residual activity at a level intermediate between p.P453S and p.I172N. This suggested that p.H62L was a mild mutation, whereas a synergistic effect occurred when it was associated. Analysis of p.H62L in a three-dimensional model structure of the CYP21 protein explained the observed in vitro effects, the H62 being located in a domain implied in membrane anchoring.
According to phenotype and functional studies, p.H62L is a mild mutation, responsible for a more severe phenotype when associated with another mild mutation. These data are important for patient management and genetic counseling.
类固醇21-羟化酶缺乏症是导致先天性肾上腺增生最常见的酶缺陷,常见突变具有良好的基因型/表型关系。确定罕见突变的严重程度对于遗传咨询以及更好地理解细胞色素P450c21的结构功能至关重要。
p.H62L突变是在2900例类固醇21-羟化酶缺乏症患者中检测到的60种新突变中最常见的,这些患者要么是孤立的该突变,要么是在同一等位基因上与轻度突变(p.P453S、p.P30L或部分启动子)相关。由于孤立或相关p.H62L的患者之间表型似乎有所不同,因此进行了详细的表型描述和功能研究。
关于表型,孤立p.H62L的患者具有非经典形式,而p.H62L + 轻度突变相关的患者具有单纯男性化形式。功能研究表明,p.H62L与轻度p.P453S一样,以相同方式降低了两种底物孕酮和17-羟孕酮的转化率;p.H62L + p.P453S组合更强烈地降低了酶活性,同时保留的残余活性处于p.P453S和p.I172N之间的中间水平。这表明p.H62L是一种轻度突变,而当其相关时会产生协同效应。在CYP21蛋白的三维模型结构中对p.H62L的分析解释了观察到的体外效应,H62位于与膜锚定相关的结构域中。
根据表型和功能研究,p.H62L是一种轻度突变,与另一种轻度突变相关时会导致更严重的表型。这些数据对于患者管理和遗传咨询很重要。